Top

Automotive OEM Coatings Market in Europe 2015-2019

Category : Materials & Chemicals  | Published Date : Jul-2015 | Pages : 60
enquire GET DISCOUNT
About Automotive OEM Coatings

Automotive coatings are products that enhance the appearance and durability of a vehicle by protecting it from external factors such as UV radiation, extreme temperatures, and foreign particles such as stones, rubble, and debris. Automotive OEM coatings are used by automotive manufacturers for the production of new passenger cars, light commercial vehicles, and heavy commercial vehicles. Vendors in the market offer products for four different functional layers: e-coat, primer, basecoat, and clearcoat. These products can be categorized into five types: water-borne coatings, high-solid solvent-borne coatings, conventional solvent-borne coatings, powder coatings, and UV-cure coatings.

Technavio's analysts forecast the automotive OEM coatings market in Europe to grow at a CAGR of 4.89% during 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the automotive OEM coatings market in Europe for 2015-2019. 

To arrive at a ranking of the leading vendors and to calculate the market size, the report considers the revenue generated through the sales of automotive OEM coatings. 

The report also provides data on the different segments of the market based on the following criteria:
• Technology: water-borne, high-solid solvent-borne, conventional solvent-borne, powder, and UV-cure coatings
• Functional layer: e-coat, primer, basecoat, and clearcoat
• Type of vehicle: passenger cars, light commercial vehicles, heavy commercial vehicles

Technavio's report, Automotive OEM Coatings Market in Europe 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Vendors
• Axalta Coating Systems
• BASF
• PPG Industries

Other Prominent Vendors
• Akzo Nobel
• Beckers
• Henkel
• Jotun
• Kansai
• KCC
• Nippon
• Valspar
 
Market Driver
• Innovation for Cost Reduction
• For a full, detailed list, view our report

Market Challenge
• New Coating Process Technologies that Limit Consumption
• For a full, detailed list, view our report

Market Trend
• Adoption of Integrated Processes
• For a full, detailed list, view our report

Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Disease Overview
06.1 Understanding Autoimmune Diseases
06.2 Epidemiology
06.3 Etiology
06.4 Symptoms
06.5 Diagnosis
06.5.1 Medical History
06.5.2 Laboratory Examination
06.6 Disease Management
06.7 Quality of Life
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
08. Pipeline Portfolio
08.1 Pipeline Landscape: Crohn's Disease
08.2 Pipeline Landscape: Multiple Sclerosis
08.3 Pipeline Landscape: Systemic Lupus Erythematosus
08.5 Five Forces Analysis
09. Market Segmentation by Type of Disease
09.1 Rheumatoid Arthritis
09.2 Multiple Sclerosis
09.3 Psoriasis
09.4 Crohn's Disease
09.5 Ankylosing Spondylitis
09.6 Systemic Lupus Erythematosus
10. Market Segmentation by Type of Molecule
10.1.1 Small Molecules
10.1.2 Biologics
11. Market Segmentation by Route of Administration
11.1.1 Parenteral Route
11.1.2 Oral Route
12. Rheumatoid Arthritis Drugs Market in US
12.1 Market Size and Forecast
13. Multiple Sclerosis Drugs Market in US
13.1 Market Size and Forecast
14. Psoriasis Drugs Market in US
14.1 Market Size and Forecast
15. Crohn's Disease Drugs Market in US
15.1 Market Size and Forecast
16. Ankylosing Spondylitis Drugs Market in US
16.1 Market Size and Forecast
17. Systemic Lupus Erythematosus Drugs Market in US
17.1 Market Size and Forecast
18. Buying Criteria
19. Market Growth Drivers
20. Drivers and Their Impact
21. Market Challenges
22. Impact of Drivers and Challenges
23. Market Trends
24. Trends and Their Impact
25. Vendor Landscape
25.1 Competitive Scenario
25.1.1 Key News
25.1.2 Mergers and Acquisitions
25.2 Market Share Analysis 2014
25.2.1 AbbVie
25.2.2 Janssen Pharmaceuticals
25.2.3 Biogen
25.2.4 Amgen
25.2.5 F. Hoffmann-La Roche
25.3 Other and Future Prominent Vendors
26. Key Vendor Analysis
26.1 AbbVie
26.1.1 Key Facts
26.1.2 Business Overview
26.1.3 Product Segmentation by Revenue 2013
26.1.4 Product Segmentation by Revenue 2012 and 2013
26.1.5 Sales by Geography
26.1.6 Business Strategy
26.1.7 Key Developments
26.1.8 SWOT Analysis
26.2 Amgen
26.2.1 Key Facts
26.2.2 Business Overview
26.2.3 Business Segmentation by Revenue 2013
26.2.4 Product Portfolio by Revenue 2013
26.2.5 Business Segmentation by Revenue 2012 and 2013
26.2.6 Geographical Segmentation by Revenue 2013
26.2.7 Business Strategy
26.2.8 Recent Developments
26.2.9 SWOT Analysis
26.3 Biogen
26.3.1 Key Facts
26.3.2 Business Overview
26.3.3 Business Segmentation by Revenue 2013
26.3.4 Geographical Segmentation by Revenue 2013
26.3.5 Business Strategy
26.3.6 Key Developments
26.3.7 SWOT Analysis
26.4 F. Hoffmann-La Roche
26.4.1 Key Facts
26.4.2 Business Overview
26.4.3 Business Segmentation
26.4.4 Business Segmentation by Revenue 2012 and 2013
26.4.5 Sales by Geography
26.4.6 Business Strategy
26.4.7 Key Information
26.4.8 SWOT Analysis
26.5 Janssen Pharmaceuticals
26.5.1 Key Facts
26.5.2 Business Overview
26.5.3 Recent Developments
26.5.4 SWOT Analysis
27. Other Reports in the Series
List Of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Autoimmune Diseases Drugs Market in US 2014-2019 ($ millions)
Exhibit 3: Autoimmune Diseases Drugs Market in US by Type of Disease
Exhibit 4: Autoimmune Diseases Drugs Market by Type of Disease 2014
Exhibit 5: Autoimmune Diseases Drugs Market in US by Type of Molecule
Exhibit 6: Autoimmune Diseases Drugs Market in US by Route of Administration
Exhibit 7: Rheumatoid Arthritis Drugs Market in US 2014-2019 ($ millions)
Exhibit 8: Multiple Sclerosis Drugs Market in US 2014-2019 ($ millions)
Exhibit 9: Psoriasis Drugs Market in US 2014-2019 ($ millions)
Exhibit 10: Crohn's Disease Drugs Market in US 2014-2019 ($ millions)
Exhibit 11: Ankylosing Spondylitis Drugs Market in US 2014-2019 ($ millions)
Exhibit 12: Systemic Lupus Erythematosus Drugs Market in US 2014-2019 ($ millions)
Exhibit 13: Autoimmune Diseases Drugs Market in US 2014-2019 ($ millions)
Exhibit 14: AbbVie: Product Portfolio for Autoimmune Diseases
Exhibit 15: Humira: YoY Revenue in US 2009-2014 ($ millions)
Exhibit 16: Janssen: Product Portfolio for Autoimmune Diseases
Exhibit 17: Remicade: YoY Global Revenue of 2009-2014 ($ millions)
Exhibit 18: Simponi: YoY Global Revenue 2010-2014 ($ millions)
Exhibit 19: Biogen: Product Portfolio for Autoimmune Diseases
Exhibit 20: Tysabri: YoY Revenue in US 2009-2014 ($ millions)
Exhibit 21: Avonex: Revenue in US 2011-2014 ($ millions)
Exhibit 22: Plegridy: Region-Wise Revenue 2014 ($ millions)
Exhibit 23: Tecfidera: Region-Wise Revenue 2014 ($ millions)
Exhibit 24: Amgen: Product Portfolio for Autoimmune Diseases
Exhibit 25: Roche: Product Portfolio for Autoimmune Diseases
Exhibit 26: AbbVie: Product Segmentation by Revenue 2013
Exhibit 27: AbbVie: Product Segmentation by Revenue 2012 and 2013 ($ millions)
Exhibit 28: AbbVie: Sales by Geography 2013
Exhibit 29: Amgen: Business Segmentation by Revenue 2013
Exhibit 30: Amgen: Product Portfolio by Revenue 2013
Exhibit 31: Amgen: Business Segmentation by Revenue 2012 and 2013 ($ billions)
Exhibit 32: Amgen: Geographical Segmentation by Revenue 2013
Exhibit 33: Biogen: Business Segmentation by Revenue 2013
Exhibit 34: Biogen: Geographical Segmentation by Revenue 2013
Exhibit 35: Business Segmentation of F. Hoffmann-La Roche 2013
Exhibit 36: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
Exhibit 37: F. Hoffmann-La Roche: Sales by Geography 2013 (Pharmaceuticals Division)
Exhibit 38: F. Hoffmann-La Roche: Sales by Geography 2013 (Diagnostics Division)
...
Publisher Name : Technavio

SIMILAR MARKET STUDIES

Please Select Format
Single User: US $ 2500
Five User: US $ 3000
Site User: US $ 4000
Global User: US $ 10000

NEED MORE INFORMATION
Contact us
Call us +1-971-202-1575
--- or ---
help@bigmarketresearch.com
WHY BIG MARKET RESEARCH
With high quality and penned to perfection, Big Market Research is an exclusive online market to get best market research reports for your business needs and strategies. We recommend you to stop browsing as soon as you discover our website. This is because we firmly believe that once you reach here; all your business concerns will be addressed.

We have a huge collection of market research report from numerous filed which will provide you with all the necessary solution. We make sure that reports that we sell are true in context, have a quality that is unrivaled, fully integrated with equal spread of opinion. They will give you proper insights into different opportunities one may locate for their start-up pr expansion.

Let your qualms and concern be sidelined through our high end syndicated as well as customized reports.
Top